Related Experiment Video
Updated: May 12, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Hepatitis C virus targets the interferon-α JAK/STAT pathway by promoting proteasomal degradation in immune cells and
Nigel J Stevenson1, Nollaig M Bourke, Elizabeth J Ryan
1School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland. n.stevenson@tcd.ie
Abstract:
JAK/STAT signalling is essential for anti-viral immunity, making IFN-α an obvious anti-viral therapeutic. However, many HCV+ patients fail treatment, indicating that the virus blocks successful IFN-α signalling. We found that STAT1 and STAT3 proteins, key components of the IFN-α signalling pathway were reduced in immune cells and hepatocytes from HCV infected patients, and upon HCV expression in Huh7 hepatocytes. However, STAT1 and STAT3 mRNA levels were normal. Mechanistic analysis revealed that in the presence of HCV, STAT3 protein was preferentially ubiquitinated, and degradation was blocked by the proteasomal inhibitor MG132. These findings show that HCV inhibits IFN-α responses in a broad spectrum of cells via proteasomal degradation of JAK/STAT pathway components.
Insights
Hepatitis C virus (HCV) blocks interferon-alpha (IFN-α) treatment by degrading key signaling proteins STAT1 and STAT3. This proteasomal degradation prevents effective anti-viral immunity in infected patients.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Interferon-alpha (IFN-α) therapy is crucial for anti-viral immunity.
- Hepatitis C virus (HCV) infection often leads to treatment failure, suggesting viral interference with IFN-α signaling.
- The JAK/STAT pathway is central to IFN-α-mediated immune responses.
Purpose of the Study:
- To investigate the mechanism by which HCV inhibits IFN-α signaling.
- To determine the impact of HCV on key components of the IFN-α pathway, specifically STAT1 and STAT3 proteins.
Main Methods:
- Analysis of STAT1 and STAT3 protein and mRNA levels in immune cells and hepatocytes from HCV-infected patients and HCV-expressing cells.
- Mechanistic studies involving proteasomal degradation assays and the use of proteasomal inhibitor MG132.
Main Results:
- STAT1 and STAT3 protein levels were reduced in HCV-infected cells, despite normal mRNA levels.
- HCV infection led to preferential ubiquitination and proteasomal degradation of STAT3.
- Inhibition of proteasomal degradation prevented STAT3 loss in the presence of HCV.
Conclusions:
- Hepatitis C virus actively suppresses IFN-α responses by targeting JAK/STAT pathway components.
- HCV-induced proteasomal degradation of STAT1 and STAT3 is a key mechanism for immune evasion.
- Understanding this mechanism offers potential therapeutic strategies against HCV treatment resistance.
Related Concept Videos
The JAK-STAT Signaling Pathway
Hepatitis
Inhibitors of Viral Protein Synthesis
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
The Extrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

